These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2804902)

  • 1. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases.
    Grignon DJ; Ayala AG; el-Naggar A; Wishnow KI; Ro JY; Swanson DA; McLemore D; Giacco GG; Guinee VF
    Cancer; 1989 Nov; 64(10):2133-40. PubMed ID: 2804902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma.
    Grignon DJ; el-Naggar A; Green LK; Ayala AG; Ro JY; Swanson DA; Troncoso P; McLemore D; Giacco GG; Guinee VF
    Cancer; 1989 Mar; 63(6):1161-5. PubMed ID: 2917319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary renal cell carcinoma: clinical implication of DNA content analysis.
    el-Naggar AK; Ro JY; Ensign LG
    Hum Pathol; 1993 Mar; 24(3):316-21. PubMed ID: 8454276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
    Ljungberg B; Larsson P; Stenling R; Roos G
    J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
    Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
    Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
    Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
    Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
    Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
    Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of DNA ploidy in small renal cell carcinoma.
    Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
    Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
    Ruiz-Cerdá JL; Hernández M; Gomis F; Vera CD; Kimler BF; O'Connor JE; Jiménez-Cruz F
    J Urol; 1996 Feb; 155(2):459-65. PubMed ID: 8558635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ploidy and prognosis in renal carcinoma.
    Lanigan D; McLean PA; Murphy DM; Donovan MG; Curran B; Leader M
    Br J Urol; 1993 Jan; 71(1):21-4. PubMed ID: 8435731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image analysis in the determination of ploidy and prognosis in renal cell carcinoma.
    Lanigan DJ; McLean PA; Murphy DM; Donovan MG; Leader M
    Eur Urol; 1992; 22(3):228-34. PubMed ID: 1468480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sarcomas of the kidney. A clinicopathologic and DNA flow cytometric study of 17 cases.
    Grignon DJ; Ayala AG; Ro JY; el-Naggar A; Papadopoulos NJ
    Cancer; 1990 Apr; 65(7):1611-8. PubMed ID: 2155701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
    Tamaki M; Maeda S; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
    Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
    Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.